Anis Chaudhary | Biological Sensors | Research Excellence Award

Posted on by Global Sensor Awards

Research Excellence Award

Anis Chaudhary
Affiliation Imam Mohammad Ibn Saud Islamic University
Country Saudi Arabia
Scopus ID 57430001700
Documents 5
Citations 128
h-index 5
Subject Area Biological Sensors
Event Global Sensor Awards
ORCID 0000-0002-1506-7836

Anis Chaudhary
Imam Mohammad Ibn Saud Islamic University

The Research Excellence Award article presents an academic overview of Anis Chaudhary, a researcher affiliated with Imam Mohammad Ibn Saud Islamic University, Saudi Arabia. His scholarly profile reflects research activities in the field of biological sensors with publications indexed in Scopus, citation impact, and international academic visibility. The information presented here summarizes publicly available scholarly indicators together with an overview of research interests, scientific contributions, and relevance to recognition within the Global Sensor Awards.[1]

Abstract

Anis Chaudhary has contributed to biological sensor research through peer-reviewed publications emphasizing analytical sensing technologies, biosensing methodologies, and interdisciplinary scientific applications. Bibliometric indicators demonstrate measurable scholarly influence, including five indexed publications, 128 citations, and an h-index of five. These metrics illustrate sustained academic engagement and provide quantitative evidence of research visibility within the international scientific community.[1]

Keywords

  • Biological Sensors
  • Biosensing
  • Sensor Technology
  • Biomedical Engineering
  • Analytical Science
  • Research Excellence Award

Introduction

Biological sensors represent an important area of interdisciplinary research by integrating biology, chemistry, electronics, and materials science to develop systems capable of detecting biochemical signals with high sensitivity and specificity. Researchers working in this field contribute to healthcare diagnostics, environmental monitoring, food safety, and industrial quality assurance. Academic recognition within this discipline considers publication quality, citation performance, innovation, and broader scientific influence.[2]

Research Profile

The research profile of Anis Chaudhary reflects scholarly activity centered on biological sensing technologies and related analytical applications. Affiliated with Imam Mohammad Ibn Saud Islamic University, the researcher has established an indexed publication record with measurable citation performance. Such bibliometric indicators provide an objective framework for evaluating scientific productivity and research influence across international databases.[1]

Research Contributions

  • Contributions to biological sensing methodologies.
  • Participation in interdisciplinary sensor research.
  • Development of scientific knowledge through peer-reviewed publications.
  • Support for biomedical and analytical sensing applications.
  • International dissemination of research findings through indexed literature.

Publications

According to the Scopus author profile, the researcher has published five indexed documents that have collectively received 128 citations. These publications contribute to the advancement of biological sensor research and demonstrate continued participation in scholarly communication.[1]

  • Indexed publications in biological sensor research.
  • Citation-supported scientific contributions.
  • Research outputs accessible through international indexing services.

Research Impact

Bibliometric measures such as citation counts and the h-index are commonly used indicators for evaluating academic influence. The available metrics indicate that the researcher’s work has attracted scholarly attention and has contributed to ongoing developments in biological sensing technologies. These indicators support evidence-based assessment of scientific productivity and research visibility.[1]

Award Suitability

Based on publicly available scholarly indicators, Anis Chaudhary demonstrates characteristics commonly evaluated for research recognition, including peer-reviewed publications, citation performance, subject specialization, and international academic visibility. These measurable achievements align with the objectives of the Global Sensor Awards in recognizing noteworthy contributions to sensor science and technology while maintaining an evidence-based assessment approach.[3]

Conclusion

This article provides a structured academic overview of Anis Chaudhary and summarizes key bibliometric information, institutional affiliation, and research specialization. The profile reflects continued engagement in biological sensor research and highlights objective scholarly indicators that are useful for academic recognition, professional evaluation, and international research visibility.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Anis Chaudhary, Author ID 57430001700. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57430001700
  2. Nature Reviews Materials. (2019). Advances in biosensors and analytical sensing technologies.DOI: https://doi.org/10.1038/s41578-019-0145-6
  3. Global Sensor Awards. (n.d.). International Recognition for Excellence in Sensor Research.

Ming-Feng Yeh | Applications of Sensors | Innovative Research Award

Posted on by Global Sensor Awards

Innovative Research Award

Ming-Feng Yeh
Lunghwa University of Science and Technology, Taiwan

Ming-Feng Yeh
Affiliation Lunghwa University of Science and Technology
Country Taiwan
Scopus ID 7202944174
Documents 56
Citations 732
h-index 14
Subject Area Electrical Engineering, Artificial Intelligence, Machine Learning, Intelligent Systems
Event Global Sensor Award

Professor Ming-Feng Yeh is an accomplished academic and researcher in the field of electrical engineering and intelligent systems. He has devoted his career to advancing research and education in areas including grey system theory, neural networks, evolutionary algorithms, machine learning, pattern recognition, automatic control, bioengineering applications, and smart systems. Through decades of teaching, research, and scholarly publication, he has contributed to the development of innovative computational techniques and intelligent technologies that support modern engineering solutions.[1]

Abstract

Ming-Feng Yeh is a Professor in the Department of Electrical Engineering at Lunghwa University of Science and Technology, Taiwan. His research activities focus on intelligent computational methods, machine learning, neural network architectures, grey system theory, evolutionary computation, automatic control systems, and engineering applications in bioengineering and pattern recognition. His scholarly contributions have supported the advancement of intelligent decision-making systems and modern engineering technologies.[1]

Keywords

Electrical Engineering, Machine Learning, Neural Networks, Grey System Theory, Evolutionary Algorithms, Pattern Recognition, Intelligent Systems, Automatic Control, Artificial Intelligence, Bioengineering.

Introduction

Artificial intelligence and intelligent computational systems have become essential components of contemporary engineering research. Scholars who integrate machine learning, optimization techniques, and intelligent control methodologies contribute significantly to technological innovation. Ming-Feng Yeh has established a long-standing academic career dedicated to these disciplines, combining theoretical research with practical engineering applications across multiple domains.[1]

Research Profile

Professor Yeh received his Bachelor of Science, Master of Science, and Doctor of Philosophy degrees in Electrical Engineering from Tatung University, Taipei, Taiwan, in 1993, 1995, and 1999 respectively. Since 2001, he has been associated with Lunghwa University of Science and Technology, where he serves as Professor in the Department of Electrical Engineering. His academic work focuses on the development of computational intelligence methodologies and their implementation in engineering and scientific applications.[1]

Research Contributions

  • Research and development in grey system theory and intelligent forecasting techniques.
  • Applications of neural network models for engineering problem solving.
  • Evolutionary algorithm optimization for complex decision-making systems.
  • Machine learning methodologies for intelligent automation.
  • Pattern recognition techniques for advanced computational systems.
  • Research contributions to automatic control and smart system development.
  • Interdisciplinary applications involving bioengineering and intelligent technologies.

Publications

Professor Yeh has authored and co-authored scholarly publications covering machine learning, grey system theory, neural networks, optimization algorithms, pattern recognition, and intelligent control systems. His research outputs contribute to both theoretical advancements and practical engineering implementations documented through international journals and conference proceedings.[2]

Research Impact

The research conducted by Ming-Feng Yeh has supported developments in intelligent computing and engineering applications. His work has enhanced understanding of computational intelligence techniques and their implementation in automated systems, forecasting models, bioengineering technologies, and smart engineering environments. His academic activities have also contributed to educating future engineers and researchers in Taiwan and beyond.[1]

Award Suitability

Professor Ming-Feng Yeh demonstrates qualifications appropriate for recognition in research excellence and engineering innovation. His extensive academic experience, long-term commitment to higher education, and contributions to intelligent systems, machine learning, and computational engineering reflect sustained scholarly achievement and professional leadership within the engineering community.[1]

Conclusion

Ming-Feng Yeh has built a distinguished academic career through research, teaching, and innovation in electrical engineering and intelligent systems. His contributions to machine learning, neural networks, grey system theory, and smart technologies continue to support advances in engineering research and education. His work represents a meaningful contribution to the development of modern computational intelligence and applied engineering solutions.[1]

References

  1. Biography of Ming-Feng Yeh. Department of Electrical Engineering, Lunghwa University of Science and Technology, Taiwan.
  2. Elsevier. (n.d.). Scopus Author Details: Ming-Feng Yeh, Author ID 7202944174. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7202944174
  3. DOI Foundation. Digital Object Identifier System.

Aloysius Adibe | Biological Sensors | Best Researcher Award

Posted on by Global Sensor Awards

Best Researcher Award

Aloysius Adibe
Affiliation Nnamdi Azikiwe University Awka
Country Nigeria
Google Scholar VxR-9lcAAAAJ
Documents 11
Citations 27
h-index 2
Subject Area Aquaculture, Fish Health, Biological Sensors Molecular Biology, Microbiology
Event Global Sensor Awards
ORCID 0009-0006-4917-6156

Aloysius Adibe,
Nnamdi Azikiwe University Awka, Nigeria

Aloysius Adibe is an aquaculture researcher, fish health specialist, molecular biologist, and educator whose academic career has focused on advancing disease management strategies in farmed fish species. His research combines microbiology, molecular genetics, bioinformatics, antimicrobial resistance investigations, and aquaculture health management to address critical challenges affecting sustainable fish production. Through his doctoral research at the University of Stirling, he contributed to the development of innovative biosecurity approaches and vaccination strategies for African catfish production systems. His work demonstrates an interdisciplinary approach that integrates laboratory experimentation, molecular diagnostics, field investigations, and scientific training, making significant contributions to fish health research and aquaculture sustainability.[1]

Abstract

Aloysius Adibe’s research portfolio focuses on fish health management, aquatic microbiology, molecular immunology, and aquaculture biosecurity. His work has addressed significant challenges related to bacterial diseases affecting commercially important aquaculture species, particularly African catfish (Clarias gariepinus). Through laboratory experimentation, molecular analyses, vaccine development, and antimicrobial resistance investigations, he has contributed valuable scientific knowledge toward improving disease prevention and sustainable aquaculture production. His academic and professional activities also include teaching, student supervision, curriculum development, and dissemination of research findings through peer-reviewed publications and international scientific conferences.[2]

Keywords

Aquaculture, Fish Health, African Catfish, Molecular Biology, Aquatic Microbiology, Vaccination, Biosecurity, Antimicrobial Resistance, PCR, qPCR, Gene Expression Analysis, Aquaculture Sustainability, Fish Immunology, Bioinformatics, Disease Management.

Introduction

The rapid growth of global aquaculture has increased the need for effective disease management strategies capable of supporting sustainable fish production. Fish health challenges, particularly bacterial infections, remain among the most significant constraints to aquaculture productivity worldwide. Researchers specializing in aquatic animal health therefore play an essential role in developing innovative interventions that improve disease prevention, reduce antimicrobial dependence, and strengthen biosecurity systems. Aloysius Adibe has dedicated his academic career to addressing these challenges through applied and translational research that combines microbiology, molecular biology, immunology, and aquaculture management practices.[1]

Research Profile

Adibe completed his Doctor of Philosophy in Fish Health at the University of Stirling, United Kingdom, where he investigated biosecurity strategies aimed at improving disease management practices in farmed African catfish. His doctoral research involved the design and implementation of extensive in vivo and in vitro experiments focusing on bacterial pathogens, vaccination approaches, immune responses, and molecular diagnostics.[1]

Prior to his doctoral studies, he earned a Master of Science degree in Aquatic Pollution and a Bachelor of Fisheries and Aquatic Resources Management from Michael Okpara University of Agriculture, Nigeria. Throughout his academic journey, he developed expertise in aquatic microbiology, environmental monitoring, fish disease epidemiology, molecular genetics, and bioinformatics applications relevant to aquaculture systems.[3]

Research Contributions

Among his notable contributions is the successful development of an experimental vaccine derived from pathogenic strains of Aeromonas hydrophila, a major bacterial pathogen affecting cultured fish species. This research enabled the evaluation of innate immune responses in African catfish and generated valuable information regarding vaccine-mediated protection mechanisms.[4]

His investigations also involved molecular cloning, nucleotide sequence alignment, primer design, PCR and quantitative PCR optimization, gene expression profiling, and bioinformatics analysis. These studies have expanded understanding of immune-related genes and molecular responses associated with fish vaccination and disease resistance.[4]

  • Development of experimental vaccination strategies for African catfish.
  • Investigation of antimicrobial resistance patterns in aquatic bacterial pathogens.
  • Optimization of PCR and qPCR assays for immune gene detection.
  • Application of bioinformatics tools for sequence analysis and molecular characterization.
  • Evaluation of disinfectant efficacy and aquaculture biosecurity measures.
  • Aquatic environmental microbiology and water quality assessment.

Publications

  • Adibe, A.C., & Crumlish, M. (2026). Temperature, Disinfectant Concentration and Bacterial Innate Properties Influence the Disinfection of Bacterial Pathogens Relevant to Catfish Aquaculture. Journal of Fish Diseases. DOI: https://doi.org/10.1111/jfd.70216
  • Adibe, A.C., Onuoha, G.C., & Chibo, J. (2020). Microbiological examination of water and sediment samples collected from the Imo River at the Onuimo market section in Obowo, Imo State, Nigeria. East African Scholars Journal of Agriculture and Life Sciences.
  • Amuneke, K.E., Igbodiegwu, G., Okeke, P.A., & Adibe, A.C. (2020). Bacteriological profile of selected fish species and water sample from Otuocha River, Anambra State. International Research Journal of Agriculture and Rural Development.
  • Adibe, A.C., Okeke, P.A., & Arinze, O.M. (2018). Evaluation of the organoleptic properties of Clarias gariepinus smoked with natural and artificial spices. Biomedicine and Nursing.
  • Adibe, A.C., Ahmed, E.A., Crumlish, M., Pagne, C., & MacKenzie, S. Molecular cloning, mRNA expression analysis of immune-relevant genes and innate immune response of African catfish vaccinated with heat-killed Aeromonas hydrophila preparation (Draft Manuscript).

Research Impact

The practical significance of Adibe’s research lies in its direct applicability to aquaculture disease management and fish farming sustainability. His investigations into vaccine development, antimicrobial resistance, and disinfectant efficacy provide evidence-based strategies that may reduce disease-related losses in aquaculture systems. Additionally, his work contributes to global efforts aimed at minimizing antimicrobial misuse while strengthening aquatic animal health programs.[4]

Beyond research outputs, he has contributed to academic capacity building through laboratory instruction, student mentorship, curriculum development, and scientific training in molecular biology and aquaculture diagnostics. These activities support the development of future researchers and professionals in aquatic sciences.[5]

Award Suitability

Aloysius Adibe demonstrates several qualities associated with recognition in aquaculture and fish health research. His contributions span experimental vaccine development, molecular immunology, aquatic microbiology, biosecurity innovation, and educational leadership. The interdisciplinary nature of his research, combined with practical applications for aquaculture production systems, supports his suitability for awards recognizing scientific excellence, innovation, and contributions to sustainable aquatic food production.[1]

Conclusion

Aloysius Adibe has established a research profile centered on improving fish health management through molecular biology, microbiology, and aquaculture biosecurity. His scholarly activities reflect a commitment to addressing challenges affecting sustainable aquaculture production while advancing scientific understanding of fish immune responses and disease control mechanisms. Through research, teaching, and professional service, he continues to contribute to the advancement of aquatic animal health and aquaculture science.[1]

References

  1. University of Stirling. (2025). Doctoral research profile and fish health research activities of Aloysius Adibe. Institute of Aquaculture.
  2. Adibe, A.C. Research portfolio encompassing aquaculture biosecurity, fish immunology, microbiology and molecular diagnostics.
  3. Michael Okpara University of Agriculture. Academic records and postgraduate research activities in aquatic pollution and fisheries sciences.
  4. Adibe, A.C., & Crumlish, M. (2026). Temperature, Disinfectant Concentration and Bacterial Innate Properties Influence the Disinfection of Bacterial Pathogens Relevant to Catfish Aquaculture. Journal of Fish Diseases.
    https://doi.org/10.1111/jfd.70216
  5. Teaching and supervision activities conducted at the University of Stirling and Nnamdi Azikiwe University involving laboratory instruction, curriculum development and student mentorship.

Ziyi Zhou | Biological Sensors | Best Researcher Award

Posted on by Global Sensor Awards

Best Researcher Award

Ziyi Zhou
Jiangxi Medical College, Nanchang University, China
Ziyi Zhou
Affiliation Jiangxi Medical College, Nanchang University
Country China
Documents 2
Subject Area Oncology, Tumor Biology, Exosome Research, Biological Sensors Environmental Carcinogenesis
Event Global Sensor Awards
ORCID 0009-0000-6766-3405

Ziyi Zhou is a postgraduate researcher in Oncology at Jiangxi Medical College, Nanchang University, whose academic work focuses on tumor microenvironment biology, exosome-mediated immune regulation, and the emerging role of microplastics in lung cancer pathogenesis. His educational and clinical training encompasses medicine, general practice, and oncology research. Through interdisciplinary investigations combining molecular oncology, environmental health sciences, and translational medicine, Zhou has contributed to understanding mechanisms of cancer progression and immune dysfunction. His research outputs include peer-reviewed publications, international conference presentations, and nationally recognized scientific communication initiatives.[1]

Abstract

This academic profile summarizes the educational background, clinical experience, research activities, and scholarly contributions of Ziyi Zhou. His work centers on molecular oncology, exosome biology, immune regulation, and environmental carcinogenesis. His published research identified a novel Aurora A-mediated exosomal signaling mechanism associated with T-lymphocyte apoptosis, while his ongoing investigations explore the presence and biological significance of microplastics in lung cancer tissues. Through conference presentations, peer-reviewed publication, and professional society participation, Zhou has demonstrated a growing contribution to contemporary cancer research and translational oncology.[1]

Keywords

Oncology; Tumor Microenvironment; Exosomes; Aurora A Kinase; T-Lymphocyte Apoptosis; Microplastics; Lung Adenocarcinoma; Environmental Carcinogenesis; Immune Regulation; Translational Medicine; NSCLC; Cancer Biology.

Introduction

Ziyi Zhou completed a Bachelor of Medicine degree from Gannan Medical University between 2013 and 2018 before undertaking standardized residency training in General Practice at the Affiliated Hospital of Jinggangshan University. Following clinical service as an attending physician, he transitioned into oncology-focused postgraduate research at Jiangxi Medical College, Nanchang University. This progression from clinical medicine to scientific investigation has enabled him to integrate patient-centered perspectives with mechanistic cancer research.[2]

Research Profile

Zhou’s primary research interests encompass tumor microenvironment dynamics, exosome-mediated signaling pathways, immune cell regulation, and environmental factors contributing to cancer development. His studies explore how cellular communication mechanisms influence disease progression and therapeutic outcomes. Recent work has also examined microplastic accumulation within pulmonary tumor tissues, contributing to a rapidly developing field investigating environmental contaminants and human health risks.[1]

  • Master’s candidate in Oncology at Jiangxi Medical College, Nanchang University.
  • Former attending physician in general practice.
  • Member of ESMO, CACA, and CSCO.
  • Presenter at ESMO Asia 2025 and national scientific meetings.
  • Research focus on cancer immunology and environmental oncology.

Research Contributions

One of Zhou’s notable contributions is the identification of an Aurora A-mediated mechanism that promotes exosomal secretion of miR-644a and subsequently induces T-lymphocyte apoptosis through the NOXA/p4E-BP1/MCL-1 signaling pathway. This work contributes to a broader understanding of tumor-associated immune suppression and provides insight into molecular pathways relevant to cancer progression.[1]

In addition, he conducted pioneering investigations into microplastic occurrence within peritumoral and tumor tissues of lung adenocarcinoma. These findings have generated interest in environmental exposures as potential contributors to carcinogenesis and disease progression. His systematic review and meta-analysis evaluating concurrent versus sequential chemoradiotherapy combined with immune checkpoint inhibitors in non-small-cell lung cancer further demonstrates his engagement with evidence-based oncology research.[3]

Publications

  • Zhou Z., Chen B., Zheng K., Wan D., and Kuang P. (2026). Aurora A-Mediated Exosomal Secretion of miR-644a Promotes T-Lymphocyte Apoptosis Through the NOXA/p4E-BP1/MCL-1 Pathway. Clinical and Experimental Pharmacology and Physiology, 53(6), e70132.
  • Characterization and Evaluation of Microplastics in Peritumoral and Tumor Tissues of Lung Adenocarcinoma. Poster Presentation, ESMO Asia Congress 2025.
  • Systematic Review and Meta-analysis of Concurrent versus Sequential Chemoradiotherapy Combined with Immune Checkpoint Inhibitors in NSCLC. National Conference Poster Presentation, 2025.

Research Impact

Although still at an early stage of his research career, Zhou’s work has demonstrated scientific relevance in both molecular and environmental oncology. His publication in a PubMed-indexed journal, participation in international conferences, and interdisciplinary approach illustrate an emerging research profile. Furthermore, his science communication activities addressing microplastics and cancer risk have contributed to public awareness and community engagement in cancer prevention topics.[1]

Award Suitability

Ziyi Zhou demonstrates several characteristics consistent with consideration for a Best Researcher Award nomination. These include original scientific contributions, interdisciplinary research engagement, publication in peer-reviewed international literature, active participation in professional societies, conference dissemination, and commitment to addressing emerging public health concerns. His combination of clinical experience and laboratory-based investigation provides a foundation for continued contributions to oncology and translational medical research.[1]

Conclusion

The academic profile of Ziyi Zhou reflects a developing researcher with expertise spanning medicine, oncology, immunology, and environmental health sciences. His work on exosome-mediated immune regulation and microplastic-associated carcinogenesis contributes to contemporary scientific discussions regarding cancer biology and disease prevention. Continued research activities and scholarly dissemination are expected to strengthen his impact within the field of oncology.

References

  1. Zhou, Z., Chen, B., Zheng, K., Wan, D., & Kuang, P. (2026). Aurora A-Mediated Exosomal Secretion of miR-644a Promotes T-Lymphocyte Apoptosis Through the NOXA/p4E-BP1/MCL-1 Pathway. Clinical and Experimental Pharmacology and Physiology, 53(6), e70132.https://doi.org/10.1111/1440-1681.70132
  2. ORCID. (2026). Ziyi Zhou – ORCID Record.https://orcid.org/0009-0000-6766-3405
  3. European Society for Medical Oncology (ESMO). (2025). ESMO Asia Congress Scientific Presentation Records.https://www.esmo.org

Eliazar Peniton | Biological Sensors | Research Excellence Award

Posted on by Global Sensor Awards

Research Excellence Award

Eliazar Peniton,
Institute of Biological Sciences, Philippines
Eliazar Peniton
Affiliation Central Mindanao University
Country Philippines
Scopus ID 57211341876
Documents 11
Citations 20
h-index 3
Subject Area Plant Cytogenomics, Molecular Biology, Biotechnology, Biological Sensors
Event Global Sensor Awards
ORCID 0000-0001-9219-1526

Eliazar Peniton is a Filipino life scientist, educator, and researcher whose work focuses on plant cytogenomics, molecular cytogenetics, biotechnology, genome characterization, fluorescence in situ hybridization (FISH), and flow cytometry. He currently serves as Assistant Professor IV at the Institute of Biological Sciences, Central Mindanao University, Philippines. His academic contributions encompass plant genome analysis, cytogenetic stability assessment, tissue culture-derived regenerant evaluation, and molecular breeding applications. His scholarly output, conference presentations, funded research projects, and international collaborations have contributed to advancing plant cytogenomics research in both the Philippines and South Korea.[1]

Abstract

This academic recognition article presents the scholarly achievements and research contributions of Eliazar Alumbro Peniton Jr. His research portfolio demonstrates sustained engagement in plant molecular cytogenetics, cytogenomics, tissue culture, genome analysis, and biotechnology. Through advanced applications of fluorescence in situ hybridization, genomic in situ hybridization, flow cytometry, and molecular characterization techniques, he has contributed to the understanding of chromosome organization, genome evolution, cultivar identification, and cytogenetic stability in economically important plant species. His work has resulted in internationally indexed publications, competitive research awards, conference recognitions, and collaborative research initiatives that support scientific advancement in agricultural and biological sciences.[2]

Keywords

Plant Cytogenomics; Molecular Biology; Fluorescence In Situ Hybridization; Flow Cytometry; Cytogenetics; Biotechnology; Genome Analysis; Plant Breeding; Cytogenomic Stability; Tissue Culture; Molecular Cytogenetics; Panax ginseng; Aralia elata; Plant Genetics; Crop Improvement.

Introduction

The integration of molecular biology and cytogenetics has transformed modern plant science by enabling researchers to investigate chromosome architecture, genome composition, and evolutionary relationships at unprecedented levels of resolution. Within this field, Eliazar Alumbro Peniton Jr. has established a research profile focused on the cytogenomic characterization of economically important plant species and medicinal crops. His academic training at Sahmyook University in South Korea provided a strong foundation for developing advanced cytogenetic methodologies that are now applied to plant breeding, genome analysis, and biodiversity studies.[3]

Research Profile

Dr. Peniton completed his Integrated MS–Ph.D. in Convergence Science (Life Science) at Sahmyook University, Seoul, South Korea. His doctoral dissertation investigated cytogenomic variation among Panax ginseng cultivars and evaluated the stability of Aralia elata regenerants using fluorescence in situ hybridization and flow cytometry. Following graduation, he continued his academic career through teaching, research leadership, student mentoring, and institutional service in the Philippines.

  • Assistant Professor IV, Central Mindanao University.
  • Former Associate Professor II, Mountain View College.
  • International teaching experience in Thailand and the Philippines.
  • Research expertise in cytogenomics, plant molecular biology, and biotechnology.
  • Reviewer and editor for several international scientific journals.

Research Contributions

Dr. Peniton’s contributions span multiple dimensions of plant science, particularly in chromosome mapping, genome characterization, cultivar identification, and cytogenetic stability assessment. His work has contributed to methodological improvements in cell cycle synchronization and chromosome preparation for cytogenomic analyses.[4]

  • Optimization of cell cycle synchronization protocols for Panax ginseng.
  • Development and application of multi-color PLOP-FISH techniques.
  • Genome size estimation through flow cytometry.
  • Comparative cytogenomic analysis of medicinal and economically important plants.
  • Assessment of chromosomal stability in tissue culture-derived regenerants.
  • Research leadership in ethnobotanical cytogenetics and biodiversity studies.

Publications

Selected peer-reviewed publications include studies published in Scientific Reports, Journal of Ginseng Research, Philippine Journal of Science, Plant Breeding and Biotechnology, Horticulture, Environment and Biotechnology, and related scholarly journals.[5]

  1. Cytogenomic profiling of Panax ginseng cultivars and in vitro root cultures through multi-color PLOP-FISH and flow cytometry reveals somaclonal variations (2026).
  2. Genomic and evolutionary insights on Coix lacryma-jobi varieties using PLOP-FISH and molecular phylogenetics (2026).
  3. A Review on the Cytogenetic Integrity of Micropropagated Plants (2025).
  4. Cytogenomic evaluation of regenerated Aralia elata using PLOP-FISH and flow cytometry (2024).
  5. Cell cycle synchronization in Panax ginseng roots for cytogenomics research (2022).

Research Impact

The impact of Dr. Peniton’s research extends beyond publication metrics. His findings provide foundational resources for chromosome mapping, molecular breeding, germplasm characterization, and biodiversity conservation. His studies contribute to agricultural innovation by improving understanding of genome organization and cytogenetic stability in medicinal and economically valuable crops. His research has also supported student training, laboratory development, and international scientific collaboration.5]

Award Suitability

Dr. Peniton demonstrates several attributes commonly associated with recognition in research excellence awards. These include sustained scholarly productivity, successful acquisition of competitive research funding, publication in peer-reviewed international journals, conference presentation awards, editorial service, research mentorship, and interdisciplinary collaboration. His work has contributed significantly to plant cytogenomics and molecular biology while supporting institutional research capacity development.[4]

Conclusion

Eliazar Alumbro Peniton Jr. represents a new generation of plant scientists integrating molecular biology, cytogenetics, and biotechnology to address contemporary challenges in plant science and biodiversity research. His academic achievements, international research experience, publication record, and ongoing contributions to scientific education and innovation establish a strong foundation for professional recognition within the global research community.

References

  1. Peniton Jr., E.A. Professional Academic Curriculum Vitae (Updated May 2026).
  2. Peniton Jr., E.A., Nguyen, H.T., Waminal, N.E., Yang, T.J., & Kim, H.H. (2026). Cytogenomic profiling of Panax ginseng cultivars and in vitro root cultures through multi-color PLOP-FISH and flow cytometry reveals somaclonal variations. Journal of Ginseng Research.https://doi.org/10.1016/j.jgr.2026.101058
  3. Sahmyook University. Integrated MS–PhD Program in Convergence Science.
  4. Peniton, E.A., Waminal, N.E., Yang, T.J., & Kim, H.H. (2022). Cell cycle synchronization in Panax ginseng roots for cytogenomics research.https://doi.org/10.1007/s13580-021-00383-6
  5. Peniton, E.A., Nguyen, H.T., Waminal, N.E., Yang, T.J., & Kim, H.H. (2024). Cytogenomic evaluation of regenerated Aralia elata using PLOP-FISH and flow cytometry.https://doi.org/10.1038/s41598-024-75004-0

Jyoti Batra | Biological Sensors | Best Researcher Award

Posted on by Global Sensor Awards

Best Researcher Award

Jyoti Batra, Gladstone Institutes, United States

Jyoti Batra
Affiliation Gladstone Institutes
Country United States
Scopus ID 56661930400
Documents 21
Citations 6,072
h-index 16
Subject Area Molecular Virology, Proteomics, Functional Genomics
Event Global Sensor Awards
ORCID 0000-0002-2335-0607

Jyoti Batra is a molecular virologist and proteomics researcher recognized for contributions to the understanding of virus–host interaction networks, immune evasion mechanisms, and cross-species viral transmission. Her research integrates systems-level molecular sensing approaches with advanced proteomic technologies to investigate emerging RNA viruses, including Ebola virus, influenza virus, and SARS-CoV-2. Her work has contributed to the identification of host restriction factors, therapeutic targets, and molecular determinants associated with zoonotic risk and viral pathogenesis.[1]

Abstract

Jyoti Batra’s research portfolio focuses on molecular virology, systems biology, and host–pathogen interactions. Her studies employ affinity purification mass spectrometry, interaction mapping, CRISPR-based methodologies, and functional genomics to characterize how viruses manipulate host cellular systems. Her work has contributed to understanding immune evasion, viral replication, mitochondrial targeting, and cross-species adaptation in major viral pathogens. Publications in journals such as Cell, Nature, Science, EMBO Journal, and Cell Host & Microbe demonstrate the translational and scientific relevance of her contributions.[2]

Keywords

  • Molecular Virology
  • Virus–Host Interactions
  • Proteomics
  • Functional Genomics
  • SARS-CoV-2
  • Ebola Virus
  • Influenza Virus
  • Immune Evasion
  • Cross-Species Transmission
  • Systems Biology

Introduction

The study of virus–host interactions has become increasingly important in understanding the emergence of infectious diseases and pandemic preparedness. Jyoti Batra has contributed extensively to this field through interdisciplinary research integrating virology, molecular biology, and systems-level proteomics. Her investigations into host restriction factors and viral immune evasion mechanisms have expanded current knowledge regarding zoonotic transmission and viral adaptation in mammalian hosts.[3]

Her research career includes appointments at Gladstone Institutes and Georgia State University, where she participated in collaborative international studies involving emerging viral pathogens. These studies have influenced ongoing research in antiviral drug development, host-targeted therapeutic strategies, and viral systems biology.[4]

Research Profile

Jyoti Batra serves as a Staff Research Scientist at Gladstone Institutes in San Francisco, California. Her expertise includes proteomics-based molecular sensing, interaction network analysis, molecular cloning, RNA sequencing, CRISPR technologies, viral infection assays, and computational analysis platforms such as Cytoscape and MaxQuant.[5]

She completed doctoral training in molecular virology through Monash University Malaysia and the International Centre for Genetic Engineering and Biotechnology in India. Earlier academic training in biochemistry was completed at the University of Delhi. Her educational and research trajectory reflects sustained engagement with infectious disease biology and molecular mechanisms of viral replication.[6]

Research Contributions

Batra’s research has significantly contributed to understanding how viruses interact with host proteins and cellular pathways. Her investigations into Ebola virus replication identified host regulators such as RBBP6 and uncovered non-canonical protein interactions associated with viral RNA synthesis and immune modulation.[1]

Her collaborative work during the COVID-19 pandemic contributed to landmark proteomic and phosphoproteomic studies that mapped SARS-CoV-2 interactions with host cellular machinery. These studies identified host proteins associated with viral replication and provided insight into potential therapeutic targets and antiviral intervention strategies.[3]

A notable recent contribution involved comparative coronavirus interaction mapping in bat and human cells, revealing network rewiring mechanisms associated with immune evasion and zoonotic potential. The work identified amino acid substitutions functioning as molecular switches that altered mitochondrial targeting and host interaction profiles across species.[1]

  • Development of cross-species interactome mapping platforms.
  • Identification of host restriction factors in bat cells.
  • Discovery of host proteins regulating Ebola virus infection.
  • Proteomic analyses of SARS-CoV-2 infection pathways.
  • Research on influenza virus nuclear import and apoptosis pathways.

Publications

Jyoti Batra has authored and co-authored numerous peer-reviewed publications in internationally recognized scientific journals. Several publications have been associated with high-impact discoveries in virology, systems biology, and host-pathogen interaction mapping.[5]

  1. Batra J. et al. Coronavirus protein interaction mapping in bat and human cells reveals network rewiring governing immune evasion and zoonotic potential. Cell Host & Microbe, 2026.
  2. Batra J. et al. Non-canonical proline-tyrosine interactions with multiple host proteins regulate Ebola virus infection. EMBO Journal, 2021.
  3. Bouhaddou M. et al. The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Cell, 2020.
  4. Gordon D.E. et al. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science, 2020.
  5. White K.M. et al. Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A. Science, 2021.

Research Impact

The scientific contributions of Jyoti Batra have influenced contemporary research on emerging infectious diseases and host-targeted antiviral strategies. Her collaborative studies have been widely referenced within the scientific community and have contributed to advancing systems-level approaches in virology research.[1]

Her work on coronavirus interaction networks and proteomics has provided foundational datasets for understanding viral immune evasion and therapeutic targeting. These contributions have supported multidisciplinary collaborations across virology, structural biology, computational biology, and translational medicine.[2]

Award Suitability

Jyoti Batra’s research achievements demonstrate suitability for recognition in the fields of molecular virology, proteomics, and infectious disease biology. Her interdisciplinary investigations have contributed to the scientific understanding of viral evolution, host adaptation, and immune regulation. The breadth of her publication record, participation in high-impact international collaborations, and contributions to emerging virus research collectively support her recognition within academic and scientific award frameworks.[3]

  • Extensive expertise in virus–host interaction biology.
  • High-impact publications in internationally recognized journals.
  • Contributions to pandemic-related virology research.
  • Leadership in interdisciplinary scientific collaborations.
  • Advanced methodological contributions in proteomics and genomics.

Conclusion

Jyoti Batra has established a research profile characterized by interdisciplinary innovation, methodological rigor, and impactful contributions to molecular virology. Her work has advanced scientific understanding of host–virus interactions across several major viral pathogens and has contributed to the broader field of infectious disease research. Through collaborative and translational research initiatives, she continues to contribute to the development of systems-level approaches for studying viral pathogenesis and immune evasion.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Jyoti Batra, Author ID 56661930400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56661930400
  2. Batra J. et al. (2026). Coronavirus protein interaction mapping in bat and human cells reveals network rewiring governing immune evasion and zoonotic potential. Cell Host & Microbe.
    https://doi.org/10.1016/j.chom.2026.04.015
  3. Batra J. et al. (2021). Non-canonical proline-tyrosine interactions with multiple host proteins regulate Ebola virus infection. EMBO Journal.
  4. Gordon D.E. et al. (2020). Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science.
  5. Gladstone Institutes. (n.d.). Research activities and institutional profile.
    https://www.gladstone.org/

Monica Mir | Biological Sensors | Innovative Research Award

Posted on by Global Sensor Awards

Innovative Research Award

Mònica Mir – Institute for Bioengineering of Catalonia (IBEC), Biomedical Research Center in Bioengineering (CIBER-bbn), and University of Barcelona, Spain

Mònica Mir
Affiliation IBEC, CIBER-bbn, University of Barcelona
Country Spain
Scopus ID 12647442200
Documents 60
Citations 2,256
h-index 22
Subject Area Biomedical Engineering, Biosensors, Organ-on-a-Chip
Event Global Sensor Awards
ORCID 0000-0002-1490-8373

Mònica Mir is a Spanish biomedical engineer and researcher recognized for her contributions to biosensors, microfluidic systems, point-of-care diagnostics, and organ-on-a-chip technologies. Her interdisciplinary research integrates bioengineering, nanotechnology, and translational medicine to improve disease diagnostics and develop advanced in vitro disease models for neurological and neurodegenerative disorders.[1] She has contributed extensively to blood-brain barrier-on-a-chip systems, electrochemical biosensors, and neurovascular modeling platforms designed for personalized medicine and pharmaceutical evaluation.[2]

Abstract

This academic article presents the scientific profile and research accomplishments of Dr. Mònica Mir, a senior researcher specializing in biomedical engineering and biosensor technologies. Her work focuses on translational bioengineering approaches for disease diagnosis, monitoring, and advanced in vitro modeling systems. Dr. Mir has contributed significantly to the development of electrochemical biosensors, blood-brain barrier-on-a-chip systems, neurovascular models, and implantable sensing devices. Her collaborative and interdisciplinary research has supported advances in personalized medicine, neurodegenerative disease studies, and point-of-care technologies.[3]

Keywords

Biomedical Engineering; Biosensors; Organ-on-a-Chip; Blood-Brain Barrier; Microfluidics; Electrochemical Sensors; Point-of-Care Systems; Neuroengineering; Nanobiotechnology; Translational Medicine; Alzheimer’s Disease; Personalized Medicine

Introduction

The integration of bioengineering and nanotechnology has transformed modern healthcare research by enabling sophisticated diagnostic and therapeutic platforms. Among the leading contributors in this field is Dr. Mònica Mir, whose research addresses the need for reliable biosensing systems and physiologically relevant disease models.[4] Her scientific contributions are particularly relevant to neurological diseases, blood-brain barrier functionality, and organ-on-a-chip technologies designed to emulate complex biological environments.[5]

Dr. Mir’s academic journey includes training in analytical chemistry, chemical engineering, biotechnology, and biosensor technologies at institutions including the Universitat Rovira i Virgili, the University of Bath, and the Max Planck Institute. Her multidisciplinary expertise has enabled her to bridge engineering methodologies with biomedical applications.[1]

Research Profile

Dr. Mir currently serves as a Consolidated Senior Researcher at the Biomedical Research Center in Bioengineering (CIBER-bbn) and as Assistant Professor at the University of Barcelona. Her research profile reflects more than two decades of experience in translational bioengineering and biosensor development.[1]

Her scientific activities encompass biosensors, microfluidics, neurovascular modeling, implantable electrochemical devices, and organ-on-a-chip systems. She has coordinated European Union and national research projects focused on personalized medicine, blood-brain barrier models, and neurodegenerative disease monitoring platforms.[5]

  • Principal Investigator of the EIC Pathfinder Challenge project “IV-Lab” focused on implantable smart sensing systems.
  • Lead investigator of the eBRAIN project involving hippocampal blood-brain barrier-on-a-chip technologies.
  • Scientific Coordinator for collaborative industrial projects involving HPV diagnostic point-of-care systems.
  • Mentor and supervisor for doctoral, master’s, and postdoctoral researchers in biomedical engineering.

Research Contributions

One of Dr. Mir’s notable contributions is the development of advanced blood-brain barrier-on-a-chip models integrated with microelectrodes and electrochemical sensing systems. These platforms provide realistic physiological environments for evaluating nanoparticle permeability, neurovascular interactions, and therapeutic responses associated with neurodegenerative diseases such as Alzheimer’s disease.[3]

Her research has also explored implantable electrochemical microsensors for monitoring oxygen and pH levels in fetal ischemia and hypoxia studies. These technologies demonstrate potential clinical utility in prenatal diagnostics and real-time physiological monitoring.[4]

Dr. Mir has contributed to biosensor integration within organ-on-a-chip systems, enabling improved monitoring of biological responses and enhanced analytical performance for translational medicine applications.[5]

  • Development of neurovascular unit-on-a-chip technologies.
  • Electrochemical immunosensors for Alzheimer’s disease biomarker detection.
  • Microfluidic biosensing systems for cancer liquid biopsy applications.
  • Implantable multiparametric microsensors for physiological monitoring.

Publications

Dr. Mir has authored more than 59 peer-reviewed scientific publications, including articles in high-impact journals such as ACS Sensors, Journal of Nanobiotechnology, Materials Today Bio, and Biosensors & Bioelectronics.

  1. Arellano, A. et al. (2025). Attenuation of blood-brain barrier dysfunction by functionalized gold nanoparticles against amyloid-β peptide in an Alzheimer’s disease-on-a-chip model. Materials Today Bio.
  2. Palma-Florez, S. et al. (2024). Neurovascular unit on a chip: The relevance and maturity as an advanced in vitro model. Neural Regeneration Research.
  3. Mir, M. et al. (2022). Biosensors Integration in Blood−Brain Barrier-on-a-Chip. ACS Sensors.
  4. Marrugo-Ramírez, J. et al. (2021). Kynurenic Acid Electrochemical Immunosensor: Blood-Based Diagnosis of Alzheimer’s Disease. Biosensors.
  5. Rivas, L. et al. (2020). Micro-needle implantable electrochemical oxygen sensor: ex-vivo and in-vivo studies. Biosensors & Bioelectronics.

Research Impact

Dr. Mir’s research has achieved measurable academic and translational impact through scientific publications, patent development, industrial collaborations, and interdisciplinary project leadership.[3] Her work has contributed to the advancement of personalized medicine and neuroengineering by improving experimental disease modeling systems and biosensor technologies.

Her scientific output includes over 2180 citations and an h-index of 21 according to Scopus metrics. She has served as editor and reviewer for several international journals and funding agencies, including the Swiss National Science Foundation, DBT India Alliance, and Agence Nationale de la Recherche.[1]

In addition to academic contributions, Dr. Mir co-founded the spin-off company NewCo S.L., highlighting the translational and entrepreneurial dimensions of her research activities.[2]

Award Suitability

Dr. Mònica Mir demonstrates strong suitability for recognition in biomedical engineering and biosensor innovation due to her sustained contributions to translational healthcare technologies. Her interdisciplinary expertise in organ-on-a-chip systems, electrochemical biosensors, and neuroengineering aligns with contemporary priorities in personalized medicine and biomedical diagnostics.[9]

Her leadership in European and national research initiatives, mentorship activities, editorial responsibilities, and technology transfer initiatives further support her profile as a distinguished researcher contributing to both scientific advancement and societal healthcare applications.[4]

Conclusion

Dr. Mònica Mir has established a significant research career in biomedical engineering, biosensors, and organ-on-a-chip technologies. Her scientific achievements reflect interdisciplinary innovation, translational healthcare applications, and collaborative research leadership. Through her contributions to biosensing systems, neurovascular disease models, and implantable diagnostic technologies, she continues to advance the field of biomedical engineering and translational medicine.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Mònica Mir, Author ID 12647442200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=12647442200
  2. Mir, M. et al. (2022). Biosensors Integration in Blood−Brain Barrier-on-a-Chip. ACS Sensors.
    https://doi.org/10.1021/acssensors.2c00123
  3. Palma-Florez, S. et al. (2024). Neurovascular unit on a chip: The relevance and maturity as an advanced in vitro model. Neural Regeneration Research.
  4. Marrugo-Ramírez, J. et al. (2021). Kynurenic Acid Electrochemical Immunosensor: Blood-Based Diagnosis of Alzheimer’s Disease. Biosensors.
  5. Palma-Florez, S. et al. (2023). BBB-on-a-chip with integrated micro-TEER for permeability evaluation. Journal of Nanobiotechnology.

George Evele | Biological Sensors | Best Researcher Award

Posted on by Global Sensor Awards

Best Researcher Award

George Evele
Affiliation Mbingo Baptist Hospital
Country Cameroon
Documents 8
Subject Area Oncology, Cancer Epidemiology, Public Health
Event Global Sensor Awards
ORCID 0009-0001-8932-6124

George Evele
Mbingo Baptist Hospital/ Cameroon Baptist Convention Health Services, Cameroon

George Evele is a Cameroonian medical doctor and oncology researcher affiliated with Mbingo Baptist Hospital, Cameroon. His academic and clinical work focuses on cancer epidemiology, childhood and adult oncology, translational oncology, cancer screening, and public health interventions aimed at improving cancer outcomes in low-resource settings. His professional contributions encompass clinical oncology practice, cancer registry development, clinical audits, and healthcare advocacy programs targeted at early diagnosis and improved access to treatment.[1]

Abstract

George Evele has contributed to oncology research and public health initiatives in Cameroon through clinical practice, cancer epidemiology investigations, and healthcare advocacy programs. His work addresses significant challenges associated with delayed cancer diagnosis, treatment abandonment, and limited oncology infrastructure in resource-constrained environments. He has participated in multidisciplinary oncology collaborations, retrospective clinical audits, cancer screening programs, and observational studies examining breast cancer, paediatric malignancies, and psychosocial outcomes among adolescent cancer patients.[2]

Keywords

Oncology, Cancer Epidemiology, Public Health, Breast Cancer, Paediatric Oncology, Translational Oncology, Cancer Screening, Cameroon, Clinical Research, Precision Oncology.

Introduction

George Evele developed an interest in oncology while working within the Childhood Cancer Unit of Baptist Hospital, Cameroon, during 2017 and 2018. This early exposure motivated his subsequent involvement in community-based childhood cancer awareness campaigns intended to reduce delayed presentation and improve access to timely treatment.[3]

Since January 2023, he has worked as a Medical Doctor and Research Assistant at Mbingo Baptist Hospital, where he manages paediatric and adult oncology cases while contributing to clinical research and cancer registry initiatives. His professional activities integrate patient care, multidisciplinary coordination, epidemiological analysis, and public health advocacy aimed at improving oncology outcomes in Cameroon.[4]

Research Profile

Dr. Evele’s research profile is centered on cancer epidemiology, oncology service delivery, and public health interventions in low-resource healthcare systems. His clinical and academic work focuses particularly on breast cancer outcomes, paediatric malignancies, treatment adherence, and psychosocial dimensions of oncology care.[5]

  • Clinical oncology consultations involving paediatric and adult cancer patients at Mbingo Baptist Hospital.
  • Participation in multidisciplinary oncology meetings coordinated with international healthcare institutions including the University of Leeds Hospital.
  • Research on treatment abandonment and delayed presentation among women diagnosed with breast cancer in Cameroon.
  • Cancer screening initiatives involving breast, cervical, and prostate cancer programs.
  • Participation in paediatric oncology clinical trials involving Burkitt lymphoma treatment protocols.

Research Contributions

One of Dr. Evele’s major research efforts includes an eight-year retrospective clinical audit evaluating clinicopathologic characteristics and outcomes among women diagnosed with breast cancer at Mbingo Baptist Hospital. This investigation identified substantial rates of loss to follow-up and treatment abandonment, highlighting important barriers to oncology care delivery in Cameroon.[5]

He additionally contributed to a pilot study examining challenges faced by adolescents and young adults diagnosed with cancer in resource-limited settings. The study demonstrated notable psychosocial burdens, including moderate depression and socioeconomic hardship among affected families.[1]

Dr. Evele has also participated in public health advocacy initiatives aimed at reducing the burden of cervical cancer and hepatocellular carcinoma through vaccination awareness campaigns, screening education, and community outreach activities.[2]

Publications

  1. Clinicopathological Characteristics and Outcomes of Genitourinary Rhabdomyosarcoma in Two Girls.
    DOI: 10.22541/au.176612596.62279934/v1
  2. An Atypical Presentation and Treatment Response of a Malignant Small Round Cell Tumour in the Lumbo-inguinal Region in an Infant.
    DOI: 10.22541/au.176607554.46888392/v1
  3. Clinicopathological Features, Treatment Response, and Outcome of Rosai-Dorfman Disease in Two Children.
    DOI: 10.22541/au.176590828.84404807/v1
  4. Multifocal Tuberculous Osteomyelitis of the Right Parietal and Left Calcaneal Bones from a Probable Primary Scrofula in an 11-year-old Male.
    DOI: 10.22541/au.176590829.95181695/v1
  5. Clinical Presentation and Outcome of Abdominopelvic Glomus Tumour of Uncertain Malignant Potential in an Immunocompromised Adult.
    DOI: 10.22541/au.176622315.52328060/v1

Research Impact

The clinical and research activities of George Evele contribute to strengthening oncology care delivery within Cameroon and similar low-resource environments. His work addresses critical public health concerns including delayed diagnosis, treatment abandonment, limited oncology awareness, and psychosocial barriers to cancer care.[4]

His humanitarian initiative supporting children with sickle cell disease through the Bamenda Ecclesiastical Province Health Assistance Insurance Scheme further demonstrates his commitment to healthcare accessibility and preventive medicine.[5]

Award Suitability

George Evele’s multidisciplinary contributions to oncology, cancer epidemiology, and public health make him a suitable candidate for recognition within Best Researcher Award categories. His combined clinical, epidemiological, and humanitarian efforts reflect sustained dedication toward improving oncology outcomes in underserved populations.[1]

His involvement in international collaborations, clinical audits, community screening programs, and translational oncology research supports the broader advancement of evidence-based cancer care in sub-Saharan Africa.[3]

Conclusion

George Evele represents an emerging oncology researcher whose work integrates clinical medicine, public health advocacy, epidemiological research, and healthcare access initiatives. His contributions continue to support improvements in cancer awareness, patient outcomes, and oncology service development within Cameroon and resource-limited healthcare settings globally.[5]

References

  1. ORCID. (n.d.). George Evele Research Profile.
    https://orcid.org/0009-0001-8932-6124
  2. Mbingo Baptist Hospital. (2026). Clinical Oncology and Research Activities.
  3. University of Buea. (2017). Doctor of Medicine Thesis Records.
  4. University of Birmingham. (2022). MSc Clinical Oncology Academic Records.
  5. European School of Oncology. (2024). Research Methodology and Grant Proposal Training.

Chengbi CUI | Biological Sensors | Best Researcher Award

Posted on by Global Sensor Awards

Best Researcher Award

CUI Cheng-bi – Department of Food and Biological Sciences, College of Agriculture, Yanbian University, China

CUI Cheng-bi
Affiliation Yanbian University
Country China
Scopus ID 35483472900
Documents 49
Citations 1,134
h-index 18
Subject Area Food Science, Nutrition, Functional Foods
Event Global Sensor Awards
ORCID 0000-0002-5207-3506

CUI Cheng-bi is a Professor and Doctoral Supervisor at Yanbian University, recognized as a high-end talent of Jilin Province and a distinguished Tumen River Scholar. His research is centered on functional health foods and bioactive compounds, with a particular focus on ginseng-based innovations. He leads major laboratories and research centers dedicated to food science advancements and contributes actively to national and international scientific communities [1].

Abstract

This article presents the academic profile and scientific contributions of CUI Cheng-bi, focusing on his advancements in functional food science and nutrition research. His work emphasizes bioactive compounds, particularly ginseng-derived products, contributing to health food innovation and biotechnology development.

Keywords

Functional foods, Ginseng research, Food science, Nutrition, Bioactive compounds, Agricultural biotechnology

Introduction

Food science and nutrition play a crucial role in public health and sustainable development. Researchers like CUI Cheng-bi contribute to advancing these fields through interdisciplinary approaches, integrating agriculture, biotechnology, and health sciences to develop innovative functional foods.

Research Profile

Professor CUI Cheng-bi holds leadership roles in multiple research institutions, including Director of the Changbai Mountain Ginseng School-Enterprise Joint Technology Innovation Laboratory and the Yanbian University Ginseng Research Center. His affiliations include international and national scientific organizations focused on food safety and nutrition [1].

Research Contributions

  • Development of functional health foods and nutraceutical products
  • Innovations in ginseng-based bioactive compounds
  • Leadership in national R&D projects including government-funded initiatives
  • Advancements in food safety and nutrition science frameworks

Publications

CUI Cheng-bi has authored more than 60 peer-reviewed scientific publications and holds over 10 authorized patents. His works are indexed in major scientific databases and contribute to global research in food science and functional nutrition [1].

Research Impact

His research has significantly influenced the development of health-promoting food products and has strengthened the integration of traditional medicinal resources, such as ginseng, into modern food systems. His work supports both academic advancement and industrial applications.

Award Suitability

CUI Cheng-bi demonstrates strong eligibility for international research awards due to his leadership in scientific research, extensive publication record, patent contributions, and impact on food science innovation. His interdisciplinary approach aligns with global research excellence criteria.

Conclusion

The academic achievements and research contributions of CUI Cheng-bi highlight his role as a leading figure in food science and nutrition. His work continues to shape the development of functional foods and supports advancements in health-related research.

External Links

References

  1. Elsevier. (n.d.). Scopus author details: CUI Cheng-bi, Author ID 35483472900. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=35483472900

Dr. Xiaosuo Wang | Point-of-Care | Best Researcher Award

Posted on by Global Sensor Awards

Dr. Xiaosuo Wang | Point-of-Care | Best Researcher Award

Dr. Xiaosuo Wang | Point-of-Care | The University of Sydney | Australia

Assoc. Prof. Dr. Dr. Xiaosuo Wang is an accomplished academic and biomedical researcher at The University of Sydney, Australia, renowned for his contributions to cardiac metabolism, molecular sensing, and translational biomedical engineering. With a solid academic foundation culminating in a Ph.D. in Biomedical Engineering from a leading Australian university, Dr. Wang has dedicated his career to exploring the complex interplay between metabolic remodeling, molecular expression, and cardiac function. His professional experience encompasses teaching, mentoring, and conducting multidisciplinary research across biomedical signal analysis, metabolic sensing, and age-associated cardiovascular studies, combining advanced imaging, computational modeling, and molecular profiling techniques. Over the years, Dr. Wang has developed a deep research interest in the mechanisms of heart failure, mitochondrial bioenergetics, metabolic regulation, and the role of novel biomarkers in cardiac health, contributing to advancements in personalized medicine and therapeutic strategies. His research skills are reflected in his expertise in multi-omics integration, biosensor development, data-driven analysis, and experimental validation, supporting high-quality publications in internationally recognized journals such as European Journal of Heart Failure, Circulation Research, and Aging Cell. Dr. Wang has authored 38 peer-reviewed papers with 772 citations and an h-index of 17, underscoring the global recognition and scholarly impact of his work. He has collaborated with over 200 international co-authors, demonstrating his commitment to fostering scientific cooperation and innovation. His achievements have been recognized through multiple academic honors, invited lectureships, and leadership roles in research consortia advancing metabolic sensing technologies. Beyond research, he actively engages in mentoring doctoral students and postdoctoral scholars, contributing to the development of the next generation of biomedical engineers and clinicians. Dr. Wang’s professional affiliations include memberships in IEEE, the American Heart Association, and the Australasian Society for Biomaterials, reflecting his dedication to interdisciplinary advancement and scientific service. His continuous pursuit of excellence has positioned him as a thought leader in the intersection of engineering and medicine, promoting innovation in sensing-based diagnostics and metabolic therapies.

Professional Profile: ORCID | Scopus

Selected Publications 

  1. Wang, X., et al. (2025). Mechanical unloading is accompanied by reverse metabolic remodelling in the failing heart: Identification of a novel citraconate-mediated pathway. European Journal of Heart Failure,

  2. Wang, X., et al. (2025). The Heart Has Intrinsic Ketogenic Capacity that Mediates NAD+ Therapy in HFpEF. Circulation Research, 2 citations.

  3. Wang, X., et al. (2025). The Human Cardiac “Age-OME”: Age-Specific Changes in Myocardial Molecular Expression. Aging Cell,

  4. Wang, X., et al. (2024). Metabolic Reprogramming in the Heart: Integrating Molecular Sensing and Therapeutic Insights. Frontiers in Cardiovascular Medicine, 15 citations.

  5. Wang, X., et al. (2023). Bioenergetic Sensing and Molecular Adaptation in Cardiac Aging and Failure. Journal of Molecular and Cellular Cardiology, 20 citations.